GeneDx

Yahoo Finance • 12 days ago

3 Stocks That May Be Trading Below Estimated Fair Value

As the U.S. stock market navigates through a government shutdown and unexpected private-sector job losses, major indices like the Nasdaq and S&P 500 continue to show resilience, with recent gains bringing them near record highs. In this fl... Full story

Yahoo Finance • 13 days ago

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

Truveta co‑founder and longtime Microsoft leader joins Executive Leadership Team GAITHERSBURG, Md., September 30, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today... Full story

Yahoo Finance • 14 days ago

Babcock & Wilcox secures initial $10M order wet gas scrubbing tech for Canada refinery

* Babcock & Wilcox (NYSE:BW [https://seekingalpha.com/symbol/BW]) received [https://seekingalpha.com/pr/20246738-babcock-and-wilcox-receives-advanced-wet-gas-scrubbing-technology-award-for-refinery-in] an initial $10 million order as par... Full story

Yahoo Finance • 25 days ago

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GAITHERSBURG, Md., September 18, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Thomas Fuchs, Dr.sc., Chief AI Officer at Eli Lilly... Full story

Yahoo Finance • last month

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from al... Full story

Yahoo Finance • last month

GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating GeneDx Holdings Corp. on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in GeneDx and would like to discuss your... Full story

Yahoo Finance • 2 months ago

GeneDx Holdings stock hits 52-week high at 127.88 USD

GeneDx Holdings Corp stock reached a 52-week high of 127.88 USD, marking a significant milestone for the company. According to InvestingPro data, the company’s financial health is rated as GOOD, with liquid assets exceeding short-term obli... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK ETF bolsters biotech, trims defense stock

Cathie Wood’s ARK ETF published their daily trades for Monday, August 18th, 2025, showcasing a continued focus on the biotech sector while reducing exposure in defense. The largest trade of the day was the purchase of 170,471 shares of Gen... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK ETFs make major buys in Deere & Co, Exact Sciences stock

Cathie Wood’s ARK ETF published their daily trades for Thursday, 14th August 2025, revealing a series of significant stock purchases across various sectors. Topping the list in dollar value was the acquisition of 64,789 shares of DEERE & C... Full story

Yahoo Finance • 2 months ago

GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in GeneDx and would like to discuss your... Full story

Yahoo Finance • 2 months ago

GeneDx at Canaccord Conference: Expanding Genomic Horizons

On Tuesday, 12 August 2025, GeneDx Holdings Corp (NASDAQ:WGS) presented at Canaccord Genuity’s 45th Annual Growth Conference, showcasing a robust second quarter driven by a surge in demand for genomic testing services. While the company hi... Full story

Yahoo Finance • 2 months ago

GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in GeneDx and would like to discuss your... Full story

Yahoo Finance • 2 months ago

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder litigation firm, alerts investors that it is investigating whether GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS... Full story

Yahoo Finance • 2 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

OPKO Health, Inc. Conference call begins at 4:30 p.m. Eastern time today MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 3... Full story

Yahoo Finance • 2 months ago

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

LOS ANGELES, July 30, 2025 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS) invest... Full story

Yahoo Finance • 2 months ago

GeneDx raises 2025 revenue guidance to $415M and exome/genome revenue growth to 52% while accelerating NICU and pediatric market expansion

Earnings Call Insights: GeneDx Holdings Corp. (WGS) Q2 2025 MANAGEMENT VIEW * Katherine A. Stueland, President and CEO, highlighted that GeneDx achieved a milestone by delivering over $100 million in quarterly revenue for the first tim... Full story

Yahoo Finance • 2 months ago

GeneDx Holdings Corp. Q2 Earnings Summary

(RTTNews) - Below are the earnings highlights for GeneDx Holdings Corp. (WGS): Earnings: $10.81 million in Q2 vs. -$29.17 million in the same period last year. EPS: $0.36 in Q2 vs. -$1.10 in the same period last year. Revenue: $102.69 mil... Full story

Yahoo Finance • 2 months ago

GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Technical Strength for Potential Upside

High-growth momentum investing focuses on identifying companies with strong earnings growth, positive analyst updates, and increasing profit margins, all while showing promising technical patterns for potential upward moves. This method bl... Full story

Yahoo Finance • 3 months ago

GeneDx Holdings Corp. Q2 2025 Earnings Preview

* GeneDx Holdings Corp. (NASDAQ:WGS [https://seekingalpha.com/symbol/WGS]) is scheduled to announce Q2 earnings results on Tuesday, July 29th, before market open. * The consensus EPS Estimate is $0.11 [https://seekingalpha.com/symbol/W... Full story

Yahoo Finance • 3 months ago

ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGS

NEW YORK, July 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from all... Full story